drugset / Trial / NCT03540355
Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of Cipros 20 association in the treatment of dyslipidemia treatment.
Timeline
- Start
- 2021-03-02
- Primary completion
- 2025-01-23
- Completion
- 2025-01-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cipros 20 association | Unknown | — | Oral |
| Comparator | Rosuvastatin | Small molecule | 20 mg | Oral |